BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36284058)

  • 1. Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection.
    Malandrino D; Berni A; Fibbi B; Borellini B; Cozzi D; Norello D; Fattirolli F; Lavorini F; Olivotto I; Fumagalli C; Zocchi C; Tassetti L; Gozzi L; Marchionni N; Maggi M; Peri A;
    J Endocrinol Invest; 2023 Mar; 46(3):577-586. PubMed ID: 36284058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.
    Berni A; Malandrino D; Corona G; Maggi M; Parenti G; Fibbi B; Poggesi L; Bartoloni A; Lavorini F; Fanelli A; Scocchera G; Nozzoli C; Peris A; Pieralli F; Pini R; Ungar A; Peri A
    Eur J Endocrinol; 2021 May; 185(1):137-144. PubMed ID: 33950864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection.
    de La Flor JC; Gomez-Berrocal A; Marschall A; Valga F; Linares T; Albarracin C; Ruiz E; Gallegos G; Gómez A; de Los Santos A; Rodeles M
    Med Clin (Barc); 2022 Jul; 159(1):12-18. PubMed ID: 34635318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia in Coronavirus Disease-19 Patients: A Retrospective Analysis.
    Machiraju PK; Alex NM; Safinaaz ; Vadamalai V
    Can J Kidney Health Dis; 2021; 8():20543581211067069. PubMed ID: 35003754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate therapy of euvolemic hyponatremia, the most frequent type of hyponatremia in SARS-CoV-2 infection, is associated with increased mortality in COVID-19 patients.
    Pazos-Guerra M; Ruiz-Sánchez JG; Pérez-Candel X; López-Nevado C; Hernández-Olmeda F; Cuesta-Hernández M; Martín-Sánchez J; Calle-Pascual AL; Runkle-de la Vega I
    Front Endocrinol (Lausanne); 2023; 14():1227059. PubMed ID: 37560297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection.
    de La Flor JC; Gomez-Berrocal A; Marschall A; Valga F; Linares T; Albarracin C; Ruiz E; Gallegos G; Gómez A; de Los Santos A; Rodeles M
    Med Clin (Engl Ed); 2022 Jul; 159(1):12-18. PubMed ID: 35784827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia is associated with poor outcome in COVID-19.
    De Carvalho H; Letellier T; Karakachoff M; Desvaux G; Caillon H; Papuchon E; Bentoumi-Loaec M; Benaouicha N; Canet E; Chapelet G; Le Turnier P; Montassier E; Rouhani A; Goffinet N; Figueres L
    J Nephrol; 2021 Aug; 34(4):991-998. PubMed ID: 33826113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.
    Ruiz-Sánchez JG; Núñez-Gil IJ; Cuesta M; Rubio MA; Maroun-Eid C; Arroyo-Espliguero R; Romero R; Becerra-Muñoz VM; Uribarri A; Feltes G; Trabattoni D; Molina M; García Aguado M; Pepe M; Cerrato E; Alfonso E; Castro Mejía AF; Roubin SR; Buzón L; Bondia E; Marin F; López Pais J; Abumayyaleh M; D'Ascenzo F; Rondano E; Huang J; Fernandez-Perez C; Macaya C; de Miguel Novoa P; Calle-Pascual AL; Estrada Perez V; Runkle I;
    Front Endocrinol (Lausanne); 2020; 11():599255. PubMed ID: 33329400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Hyponatremia Among Critically Ill Patients With and Without COVID-19 Infection at a Community Teaching Hospital.
    Gustafson BD; Zhao Y; Milkovits AE; Kamrada ME
    J Intensive Care Med; 2023 Oct; 38(10):911-916. PubMed ID: 37078093
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest Radiograph Severity and Its Association With Outcomes in Subjects With COVID-19 Presenting to the Emergency Department.
    Kotok D; Robles JR; E Girard C; K Shettigar S; P Lavina A; R Gillenwater S; I Kim A; Hadeh A
    Respir Care; 2022 Jul; 67(7):871-878. PubMed ID: 35473787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-rater reliability and prognostic value of baseline Radiographic Assessment of Lung Edema (RALE) scores in observational cohort studies of inpatients with COVID-19.
    Al-Yousif N; Komanduri S; Qurashi H; Korzhuk A; Lawal HO; Abourizk N; Schaefer C; Mitchell KJ; Dietz CM; Hughes EK; Brandt CS; Fitzgerald GM; Joyce R; Chaudhry AS; Kotok D; Rivera JD; Kim AI; Shettigar S; Lavina A; Girard CE; Gillenwater SR; Hadeh A; Bain W; Shah FA; Bittner M; Lu M; Prendergast N; Evankovich J; Golubykh K; Ramesh N; Jacobs JJ; Kessinger C; Methe B; Lee JS; Morris A; McVerry BJ; Kitsios GD
    BMJ Open; 2023 Jan; 13(1):e066626. PubMed ID: 36635036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study.
    Russo A; Pisaturo M; De Luca I; Schettino F; Maggi P; Numis FG; Gentile I; Sangiovanni V; Rossomando AM; Gentile V; Calabria G; Rescigno C; Megna AS; Masullo A; Manzillo E; Russo G; Parrella R; Dell'Aquila G; Gambardella M; Ponticiello A; Reginelli A; Coppola N;
    J Infect Public Health; 2023 Jan; 16(1):136-142. PubMed ID: 36521329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.